- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01773343
Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals
January 18, 2013 updated by: Aarhus University Hospital
Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals. A Randomized Controlled Trial With Blinded Response Evaluations
To compare efficacy and adverse effects of fractional CO2 laser of acne scars treatment with 1 versus 3 months intervals
Study Overview
Detailed Description
Change in scar texture evaluated by blinded evalutaions.
Appearance of erythema, oedema, pigmentation, infection after treatment
Study Type
Interventional
Enrollment (Anticipated)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Aarhus C
-
Aarhus, Aarhus C, Denmark, 8000
- Aarhus University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have Fitzpatrick skin type I-III. (•Are male or female.
- Are between 18 and 60 years of age.
- Mild to severe acne scarring.
- Are able to read, understand, and sign the Informed Consent.
- Are willing and able to comply with all follow-up requirements -
Exclusion Criteria:
- Have had active localized or systemic infections within 6 months of enrollment
- Have compromised ability for wound healing, such as: malnutrition, oral steroid use, history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid formation (raised and thickened scars), atrophic dermatitis (extreme skin irritation or itchiness) or immunologic abnormalities such as vitiligo (white patches of skin due to loss of pigment)
- Have been treated with lasers, chemical procedures, or other cosmetic procedures on the area to be treated within 6 months of enrollment
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: CO2 laser at 1 month interval
CO2 laser treatment of mild to severe acne scars at 1 month interval
|
Fractionel CO2 laser: 1 versus 3 months intervals
Other Names:
|
ACTIVE_COMPARATOR: CO2 laser at 3 monrths interval
CO2 laser treatment of mild to severe acne scars at 3 month intervals
|
Fractionel CO2 laser: 1 versus 3 months intervals
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in scar texture
Time Frame: 24 weeks
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Appearance of erythema, oedema, pigmentation, infection
Time Frame: 24 weeks
|
24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Lene Hedelund, MD, PhD, Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (ANTICIPATED)
January 1, 2013
Study Completion (ANTICIPATED)
January 1, 2013
Study Registration Dates
First Submitted
January 2, 2013
First Submitted That Met QC Criteria
January 18, 2013
First Posted (ESTIMATE)
January 23, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
January 23, 2013
Last Update Submitted That Met QC Criteria
January 18, 2013
Last Verified
January 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 100169
- 20110102 (20110102)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atrophic Acne Scars
-
Ulthera, IncCompleted
-
Suneva Medical, Inc.ethica Clinical Research Inc.CompletedAtrophic Acne ScarsUnited States
-
IBSA Farmaceutici Italia SrlDerming SRLCompletedAcne Scars - Mixed Atrophic and Hypertrophic | Ice Pick Scars | Rolling Scars | Boxcar ScarsItaly
-
AbbVieRecruitingAtrophic Acne ScarsCanada, Germany
-
Assiut UniversityNot yet recruitingAcne Scars - AtrophicEgypt
-
Damascus UniversityCompleted
-
Jinnah Postgraduate Medical CentreCompleted
-
Damascus UniversityCompletedAtrophic Acne ScarsSyrian Arab Republic
-
Galderma R&DCompletedAcne Vulgaris | Atrophic Acne ScarsFrance, Canada
-
Zagazig UniversityNot yet recruitingAcne Scars - Mixed Atrophic and Hypertrophic
Clinical Trials on Laser
-
Manchester University NHS Foundation TrustTopcon Corporation; Optos, PLCWithdrawnDiabetic Macular OedemaUnited Kingdom
-
University of Sao Paulo General HospitalCompletedOsteoarthritisBrazil
-
Mashhad University of Medical SciencesUnknownTemporomandibular Joint Disorder
-
State University of Minas GeraisFundação de Amparo à Pesquisa do estado de Minas GeraisActive, not recruiting
-
Universidade Norte do ParanáUniversidade Estadual de LondrinaCompletedPerformance | Aged | Muscle Strength | Resistance Training | LasersBrazil
-
Northwestern UniversityEnrolling by invitation
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
Federal University of Health Science of Porto AlegreUnknown
-
Beijing HospitalNot yet recruitingCentral Serous Chorioretinopathy
-
Sun Yat-sen UniversityUnknownDiabetic Macular EdemaChina